Microbix Biosystems Inc. (MBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$83.95K ≈ $60.73K USD) by net assets (CA$27.79 Million ≈ $20.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Microbix Biosystems Inc. - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Microbix Biosystems Inc. debt and liabilities for a breakdown of total debt and financial obligations.
Microbix Biosystems Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbix Biosystems Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ovaro Kiinteistosijoitus Oyj
HE:OVARO
|
-0.048x |
|
Pamapol S.A.
WAR:PMP
|
-0.041x |
|
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD
|
-0.093x |
|
Shinpoong Pharmaceutical Co Ltd
KO:019175
|
0.013x |
|
Zenith Minerals Ltd
AU:ZNC
|
-0.078x |
|
Adore Beauty Group Ltd
AU:ABY
|
0.171x |
|
System1 Inc
NYSE:SST
|
-0.611x |
|
Eurotel SA
WAR:ETL
|
0.124x |
Annual Cash Flow Conversion Efficiency for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual cash flow conversion efficiency of Microbix Biosystems Inc. from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see MBX stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$27.79 Million ≈ $20.10 Million |
CA$-80.29K ≈ $-58.08K |
-0.003x | -101.88% |
| 2024-09-30 | CA$28.30 Million ≈ $20.47 Million |
CA$4.35 Million ≈ $3.15 Million |
0.154x | +445.65% |
| 2023-09-30 | CA$24.62 Million ≈ $17.81 Million |
CA$-1.09 Million ≈ $-791.79K |
-0.044x | -131.99% |
| 2022-09-30 | CA$24.94 Million ≈ $18.04 Million |
CA$3.47 Million ≈ $2.51 Million |
0.139x | +22.39% |
| 2021-09-30 | CA$18.56 Million ≈ $13.42 Million |
CA$2.11 Million ≈ $1.52 Million |
0.114x | +8673.40% |
| 2020-09-30 | CA$6.62 Million ≈ $4.79 Million |
CA$8.57K ≈ $6.20K |
0.001x | -69.27% |
| 2019-09-30 | CA$10.54 Million ≈ $7.62 Million |
CA$44.37K ≈ $32.10K |
0.004x | +108.12% |
| 2018-09-30 | CA$10.35 Million ≈ $7.49 Million |
CA$-537.00K ≈ $-388.46K |
-0.052x | -364.96% |
| 2017-09-30 | CA$15.17 Million ≈ $10.98 Million |
CA$297.05K ≈ $214.88K |
0.020x | -67.22% |
| 2016-09-30 | CA$15.29 Million ≈ $11.06 Million |
CA$913.31K ≈ $660.67K |
0.060x | +37.19% |
| 2015-09-30 | CA$13.68 Million ≈ $9.89 Million |
CA$595.40K ≈ $430.70K |
0.044x | +136.59% |
| 2014-09-30 | CA$9.84 Million ≈ $7.12 Million |
CA$-1.17 Million ≈ $-846.97K |
-0.119x | -258.89% |
| 2013-09-30 | CA$5.72 Million ≈ $4.14 Million |
CA$428.36K ≈ $309.87K |
0.075x | +117.64% |
| 2012-09-30 | CA$4.12 Million ≈ $2.98 Million |
CA$-1.75 Million ≈ $-1.27 Million |
-0.425x | -68.21% |
| 2011-09-30 | CA$5.15 Million ≈ $3.72 Million |
CA$-1.30 Million ≈ $-939.78K |
-0.252x | +21.42% |
| 2010-09-30 | CA$5.65 Million ≈ $4.09 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.321x | +5.76% |
| 2009-09-30 | CA$6.41 Million ≈ $4.64 Million |
CA$-2.19 Million ≈ $-1.58 Million |
-0.341x | -32.97% |
| 2008-09-30 | CA$7.62 Million ≈ $5.51 Million |
CA$-1.95 Million ≈ $-1.41 Million |
-0.256x | +67.62% |
| 2007-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.792x | +25.75% |
| 2006-09-30 | CA$1.48 Million ≈ $1.07 Million |
CA$-1.58 Million ≈ $-1.14 Million |
-1.066x | -892.57% |
| 2005-09-30 | CA$2.77 Million ≈ $2.00 Million |
CA$372.31K ≈ $269.32K |
0.135x | -30.91% |
| 2004-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$444.57K ≈ $321.60K |
0.195x | +280.59% |
| 2003-09-30 | CA$1.99 Million ≈ $1.44 Million |
CA$-214.27K ≈ $-155.00K |
-0.108x | -315.02% |
| 2002-09-30 | CA$2.12 Million ≈ $1.53 Million |
CA$106.20K ≈ $76.82K |
0.050x | -70.95% |
| 2001-09-30 | CA$2.05 Million ≈ $1.48 Million |
CA$353.56K ≈ $255.76K |
0.173x | +334.02% |
| 2000-09-30 | CA$1.76 Million ≈ $1.28 Million |
CA$-130.02K ≈ $-94.06K |
-0.074x | +90.36% |
| 1999-09-30 | CA$1.70 Million ≈ $1.23 Million |
CA$-1.30 Million ≈ $-940.40K |
-0.765x | -25.49% |
| 1998-09-30 | CA$6.40 Million ≈ $4.63 Million |
CA$-3.90 Million ≈ $-2.82 Million |
-0.609x | -2337.50% |
| 1997-09-30 | CA$8.00 Million ≈ $5.79 Million |
CA$-200.00K ≈ $-144.68K |
-0.025x | -- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more